IOM, NCI Clash Over Proposed Change in Tabulating Minority Research
In Brief: With Opening of New 13-Story Hospital, M.D. Anderson Now 4.1 M Sq. Feet
ODACSupports Temodal For Treatment of Astrocytoma
The White House: Justice Department May Sue Tobacco Firms, Clinton Says
Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch
Funding Opportunites: Society to Fund Grants In Women’s Health Research
In Brief: James Cancer Hospial Recieves $20M Donation
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
